Q2 2022 Holdings
Filed 2022-08-15 | 24 holdings | $147.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $44.6M | 4,944,708 | 30.2% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $35.1M | 893,646 | 23.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $33.7M | 2,410,622 | 22.8% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $14.5M | 538,812 | 9.8% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $11.0M | 312,533 | 7.5% |
| Celcuity Inc(CELC) | COM | 15102K100 | $8.4M | 920,464 | 5.7% |
| Merus N V | COM | N5749R100 | $59.2K | 2,615,762 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $48.5K | 1,594,932 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $41.4K | 4,479,784 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $33.5K | 1,826,491 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $23.2K | 2,409,961 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $19.6K | 2,028,453 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $19.0K | 1,638,609 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $16.9K | 5,738,500 | 0.0% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $15.4K | 3,711,286 | 0.0% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $13.2K | 739,661 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $11.5K | 13,049,079 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $8.7K | 1,935,609 | 0.0% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $3.9K | 1,210,000 | 0.0% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $3.1K | 893,013 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $3.1K | 312,553 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $2.5K | 250,000 | 0.0% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $2.0K | 357,699 | 0.0% |
| Inventiva SA(IVA) | ADS | 46124U107 | $995 | 175,500 | 0.0% |